Extending dupilumab dosing intervals in atopic dermatitis: A prospective observational study in a South European tertiary hospital
Journal of the European Academy of Dermatology and Venereology · 2024-02 · 38 (2)
DOI: 10.1111/jdv.19528 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 25.09.2023. Verfasst von C Valente und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology and Venereology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dermatology and Venereology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Zitieren
APA
Valente, C., Farinha, P., & Duarte, B. (2024). Extending dupilumab dosing intervals in atopic dermatitis: A prospective observational study in a South European tertiary hospital. Journal of the European Academy of Dermatology and Venereology, 38(2). https://doi.org/10.1111/jdv.19528
Vancouver
Valente C, Farinha P, Duarte B. Extending dupilumab dosing intervals in atopic dermatitis: A prospective observational study in a South European tertiary hospital. Journal of the European Academy of Dermatology and Venereology. 2024;38(2). doi:10.1111/jdv.19528
BibTeX
@article{Valente2024,
author = {Valente, C and Farinha, P and Duarte, B},
title = {Extending dupilumab dosing intervals in atopic dermatitis: A prospective observational study in a South European tertiary hospital},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2024},
volume = {38},
number = {2},
doi = {10.1111/jdv.19528}
}
EUVIMED